Revelations that infections with human papillomavirus (HPV) can lead to cancer have generated a great deal of interest in searching for effective and safe manners to prevent HPV. WebMD writes that HPV vaccine is an inactivated vaccine which protects you against four major types of HPV. HPV vaccine has the capacity to prevent most genital warts and most cases of cervical cancer. Family Practice News reported on Oct. 25, 2013, "New HPV vaccine promises to prevent 85% of invasive cervical cancer."
According to a spokesman for Merck, the company which is developing the product, an investigational 9-valent human papillomavirus vaccine may be able to prevent up to 85 percent of invasive cervical cancer. Five new HPV strains aside from the four which are already included in the current quadrivalent vaccine, are included in the vaccine. Dr. Luxembourg of Merck has said, "The 9-valent could increase coverage from 50% to 85% of high-grade legions – which matches the best screening program – and increase the prevention of cervical intraepithelial neoplasi."
Like the quadrivalent vaccine, the new vaccine would still be targeted at girls, women, boys, and men who are from 9-26 years old. Merck is seeking a full transition from the quadrivalent vaccine and is planning to submit a Biologics License Application to the Food and Drug Administration by the end of this year. This is a very significant development which promises to bring us closer to the goal of someday wiping out HPV.